Denali Therapeutics Inc. (DNLI) Insider Trading
Over the last 3 months, DNLI insiders made 0 open-market buys and 1 sale, a net sale of -$72K (SEC Form 4). Over the last 6 months, 230 institutions increased and 128 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
1
Net (3m)
-$71.6K
Insider trades by month Buys Sells
Jan
Jul
Aug
Dec
Jan
Aug
Context3-month price +22.7%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | Schuth Alexander O.officer: COFO and Secretary | Sell | 2,857 | $25.07 |
| Jun 5, 2026 | Van Hauwermeiren Timothydirector | Grant | 6,408 | — |
| Jun 5, 2026 | Krognes Steve E.director | Grant | 6,408 | — |
| Jun 5, 2026 | Thornberry Nancydirector | Grant | 6,408 | — |
| Jun 5, 2026 | Cook Jennifer E.director | Grant | 6,408 | — |
| Jun 5, 2026 | Klein Peter Sdirector | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | BAKER BROS. ADVISORS LPdirector | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | Klein Peter Sdirector | Grant | 6,408 | — |
| Jun 5, 2026 | FLATLEY JAY Tdirector | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | Thornberry Nancydirector | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | BAKER BROS. ADVISORS LPdirector | Grant | 6,408 | — |
| Jun 5, 2026 | Schenkein David Pdirector | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | Cook Jennifer E.director | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | FLATLEY JAY Tdirector | Grant | 6,408 | — |
| Jun 5, 2026 | Krognes Steve E.director | Grant | 19,226 | $19.66 |
| Jun 5, 2026 | Schenkein David Pdirector | Grant | 6,408 | — |
| Jun 5, 2026 | Van Hauwermeiren Timothydirector | Grant | 19,226 | $19.66 |
| Jan 8, 2026 | Watts Ryan J.director, officer: President and CEO | Sell | 35,198 | $16.50 |
| Jan 8, 2026 | Schuth Alexander O.officer: COFO and Secretary | Sell | 17,218 | $16.50 |
| Jan 5, 2026 | Watts Ryan J.director, officer: President and CEO | Grant | 236,880 | $16.27 |
| Jan 5, 2026 | Schuth Alexander O.officer: COFO and Secretary | Grant | 57,700 | — |
| Jan 5, 2026 | Watts Ryan J.director, officer: President and CEO | Grant | 78,960 | — |
| Jan 5, 2026 | Schuth Alexander O.officer: COFO and Secretary | Grant | 173,100 | $16.27 |
| Dec 15, 2025 | BAKER BROS. ADVISORS LPdirector | Buy | 2,095,191 | $0.01 |
| Dec 15, 2025 | BAKER BROS. ADVISORS LPdirector | Buy | 190,523 | $0.01 |
| Nov 6, 2025 | Van Hauwermeiren Timothydirector | Grant | 10,632 | — |
| Nov 6, 2025 | Van Hauwermeiren Timothydirector | Grant | 31,897 | $14.92 |
| Aug 14, 2025 | Ho Caroleofficer: Chief Medical Officer | Sell | 2,937 | $13.58 |
| Aug 14, 2025 | Schuth Alexander O.officer: COFO and Secretary | Sell | 2,937 | $13.58 |
| Aug 14, 2025 | Ho Caroleofficer: Chief Medical Officer | Sell | 806 | $14.64 |
Source: DNLI SEC Form 4 filings, latest Aug 13, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their DNLI positions over the last 6 months (SEC Form 13F).
Increased
230
New positions
110
Reduced
128
Sold out
30
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | Increased | 16.2M | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 14.0M | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13.0M | May 13, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 12.1M | May 8, 2026 |
| BAILLIE GIFFORD & CO | Reduced | 12.0M | Aug 6, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Increased | 8.5M | May 15, 2026 |
| STATE STREET CORP | Increased | 7.0M | Aug 7, 2026 |
| TEMASEK HOLDINGS (PRIVATE) LTD | Unchanged | 7.0M | May 12, 2026 |
| Temasek Holdings (Private) Ltd | Unchanged | 7.0M | Aug 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 6.5M | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 6.3M | Aug 13, 2026 |
| STATE STREET CORP | Increased | 6.3M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6.1M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 6.1M | May 8, 2026 |
| FMR LLC | Reduced | 4.6M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.